Laboratorios Farmaceuticos (Spain) Performance
| ROVI Stock | EUR 53.20 1.10 2.03% |
The company secures a Beta (Market Risk) of 0.48, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Laboratorios Farmaceuticos' returns are expected to increase less than the market. However, during the bear market, the loss of holding Laboratorios Farmaceuticos is expected to be smaller as well. At this point, Laboratorios Farmaceuticos has a negative expected return of -0.27%. Please make sure to verify Laboratorios Farmaceuticos' coefficient of variation, information ratio, total risk alpha, as well as the relationship between the standard deviation and jensen alpha , to decide if Laboratorios Farmaceuticos performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Laboratorios Farmaceuticos ROVI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 53.2 M | |
| Total Cashflows From Investing Activities | -40.8 M |
Laboratorios |
Laboratorios Farmaceuticos Relative Risk vs. Return Landscape
If you would invest 6,420 in Laboratorios Farmaceuticos ROVI on December 1, 2024 and sell it today you would lose (1,100) from holding Laboratorios Farmaceuticos ROVI or give up 17.13% of portfolio value over 90 days. Laboratorios Farmaceuticos ROVI is generating negative expected returns and assumes 2.5572% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Laboratorios, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Laboratorios Farmaceuticos Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratorios Farmaceuticos' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Laboratorios Farmaceuticos ROVI, and traders can use it to determine the average amount a Laboratorios Farmaceuticos' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1047
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ROVI |
Estimated Market Risk
| 2.56 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Laboratorios Farmaceuticos is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Laboratorios Farmaceuticos by adding Laboratorios Farmaceuticos to a well-diversified portfolio.
Laboratorios Farmaceuticos Fundamentals Growth
Laboratorios Stock prices reflect investors' perceptions of the future prospects and financial health of Laboratorios Farmaceuticos, and Laboratorios Farmaceuticos fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratorios Stock performance.
| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.93 B | |||
| Shares Outstanding | 51.32 M | |||
| Price To Earning | 43.87 X | |||
| Price To Book | 4.42 X | |||
| Price To Sales | 2.54 X | |||
| Revenue | 648.68 M | |||
| EBITDA | 204.66 M | |||
| Cash And Equivalents | 126.82 M | |||
| Cash Per Share | 2.26 X | |||
| Total Debt | 52.52 M | |||
| Debt To Equity | 0.18 % | |||
| Book Value Per Share | 8.28 X | |||
| Cash Flow From Operations | 149.44 M | |||
| Earnings Per Share | 3.33 X | |||
| Total Asset | 732.68 M | |||
About Laboratorios Farmaceuticos Performance
By analyzing Laboratorios Farmaceuticos' fundamental ratios, stakeholders can gain valuable insights into Laboratorios Farmaceuticos' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Laboratorios Farmaceuticos has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Laboratorios Farmaceuticos has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. LABORATORIOS FARMACEUTICOS operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1499 people.Things to note about Laboratorios Farmaceuticos performance evaluation
Checking the ongoing alerts about Laboratorios Farmaceuticos for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Laboratorios Farmaceuticos help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Laboratorios Farmaceuticos generated a negative expected return over the last 90 days | |
| About 60.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Laboratorios Farmaceuticos' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratorios Farmaceuticos' stock is overvalued or undervalued compared to its peers.
- Examining Laboratorios Farmaceuticos' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratorios Farmaceuticos' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratorios Farmaceuticos' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratorios Farmaceuticos' stock. These opinions can provide insight into Laboratorios Farmaceuticos' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |